Gene · 3588
Papers2,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,588
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel NFAT1-IL6/JAK/STAT3 signaling pathway related nomogram predicts overall survival in gliomas. | Sci Rep | 2023 | 37452092 | PubTator, text mining | PubMed |
| Cytokines as Biomarkers for Evaluating Physical Exercise in Trained and Non-Trained Individuals: A Narrative Review. | Int J Mol Sci | 2023 | 37446334 | PubTator, text mining | PubMed |
| Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severity. | Immunity | 2023 | 37442134 | PubTator, text mining | PubMed |
| Differential expression profile of genes involved in the immune response associated to progression of chronic Chagas disease. | PLoS Negl Trop Dis | 2023 | 37440604 | PubTator, text mining | PubMed |
| Implication of the Transmembrane Domain in the Interleukin 10 Receptor Platform Oligomerisation. | Cells | 2023 | 37408195 | PubTator, text mining | PubMed |
| Interleukin-22 facilitates the interferon-λ-mediated production of tripartite motif protein 25 to inhibit replication of duck viral hepatitis A virus type 1. | Vet Res | 2023 | 37391858 | PubTator, text mining | PubMed |
| Differentiation of IL-26+ TH17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis. | Nat Commun | 2023 | 37391412 | PubTator, text mining | PubMed |
| The spectrum of clinical presentation in haploinsufficiency of A20; a case report of a novel mutation in TNFAIP3 gene. | Front Pediatr | 2023 | 37388287 | PubTator, text mining | PubMed |
| RelB is a potential molecular biomarker for immunotherapy in human pan-cancer. | Front Mol Biosci | 2023 | 37388242 | PubTator, text mining | PubMed |
| Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition. | Sci Adv | 2023 | 37379383 | PubTator, text mining | PubMed |
| The Immunotherapeutic Role of Type I and III Interferons in Melanoma and Non-Melanoma Skin Cancers. | Life (Basel) | 2023 | 37374093 | PubTator, text mining | PubMed |
| Immunomodulatory Role of Interferons in Viral and Bacterial Infections. | Int J Mol Sci | 2023 | 37373262 | PubTator, text mining | PubMed |
| Inflammatory Bowel Disease: Crosstalk between Histamine, Immunity, and Disease. | Int J Mol Sci | 2023 | 37373085 | PubTator, text mining | PubMed |
| Viral recognition and the antiviral interferon response. | EMBO J | 2023 | 37367474 | PubTator, text mining | PubMed |
| Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer. | Nat Cancer | 2023 | 37365326 | PubTator, text mining | PubMed |
| Phosphomevalonate kinase deficiency expands the genetic spectrum of systemic autoinflammatory diseases. | J Allergy Clin Immunol | 2023 | 37364720 | PubTator, text mining | PubMed |
| Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling. | iScience | 2023 | 37360690 | PubTator, text mining | PubMed |
| The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. | Front Immunol | 2023 | 37359549 | PubTator, text mining | PubMed |
| PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation. | BMC Cancer | 2023 | 37349676 | PubTator, text mining | PubMed |
| The current advances of lncRNAs in breast cancer immunobiology research. | Front Immunol | 2023 | 37342324 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3588/papers?page=13